EQT expands European life sciences VC opportunities with LSP acquisition

Swedish private equity giant EQT() is expanding its footprint in the European healthcare venture capital sector after entering into an agreement to acquire Life Sciences Partners (LSP) in a deal valued at up to €475 million.

The deal calls for an upfront payment of €450 million, of which 25% would be cash and the remainder consisting of publicly traded EQT shares. An additional earn-out payment of €25 million is in the cards if undisclosed fundraising targets are met in the short term. In exchange, EQT will take control of 100% of the LSP management company and . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.

Get started

Sergio Barreto

Sergio Barreto is about 70% journalist, 30% tech geek. As an editor for The ABIS Group, he produces daily newsletters for leading healthcare and technology companies. With BMV Digital, he provides WordPress-based web developments services. Here at Alternatives Watch, he wears both hats - handling IT and occasionally writing about the intersection of alts, healthcare and tech.
Back to top button

Start Your Days in the Know

 

Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!